Cost-effectiveness of curettage versus expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: A randomized controlled trial and cohort study

Funding

Department of Obstetrics and Gynecology, Academic Medical Center (M.L., M.A.C.V., W.M.A.); Department of Obstetrics and Gynecology, VU Medical Center (M.L., J.A.F.H.); Clinical Research Unit, University of Amsterdam, Academic Medical Center (P.M.B.), Amsterdam; Department of Obstetrics and Gynecology, Leeuwarden Medical Center, Leeuwarden (T.S.); Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen (T.E.N.); Department of Obstetrics and Gynecology, Grow-School for Oncology and Developmental Biology, Maastricht University, Maastricht (M.Y.B.); Department of Obstetrics and Gynecology, Groene Hart Hospital, Gouda (I.A.H.J.); Department of Obstetrics and Gynecology, Sint Franciscus Gasthuis, Rotterdam (M.H.A.V.H.), the Netherlands; The Robinson Research Institute, School of Pediatrics and Reproductive Health, University of Adelaide and The South Australian Health and Medical Research Institute, Adelaide, Australia (B.W.J.M.); and Department of Health Sciences, Faculty of Earth and Life Sciences, Free University Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands (J.E.B.)